Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)

GAITHERSBURG, Md., March 2, 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-Mâ„¢ adjuvant, today announced that the Company granted a non-qualified stock option and restricted stock units to Elaine O’Hara, its newly…

Leave a Reply

Your email address will not be published. Required fields are marked *